895589-79-4Relevant academic research and scientific papers
COMPOUNDS HAVING ACTIVITY AT THE GLYCINE TRANSPORTER GLYT1 AND USES THEREOF
-
Page/Page column 12, (2009/09/25)
The present invention relates to compounds of formula (I), salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. Th
GLYCINE TRANSPORTER INHIBITING COMPOUNDS AND USES IN MEDICINE
-
Page/Page column 25, (2010/11/29)
Compounds of formula (I) and salts and solvates thereof are provided: wherein either 1 ) R1, R2, R3 and R4 and all methyl, or 2) R1 and R2 form a pyrrolidinyl group and R3 and R4 are both methyl, or 3) R1 and R2 are both methyl and R3 and R4 together form
GLYCINE TRANSPORTER INHIBITING COMPOUNDS AND USES IN MEDICINE
-
Page/Page column 22, (2008/06/13)
N-[[1-dimethylaminojcyclopentyl](phenyl)methyl]-4-fluoro-2-methyl-6- (methyloxy)benzamide:and salts and solvates thereof are provided. Uses in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, such as psychoses, deme
OXYGEN CONTAINING HETEROCYCLES AS GLYCINE TRANSPORTER INHIBITING COMPOUNDS
-
Page/Page column 39-40, (2008/06/13)
The present invention relates to compounds of formula (I), or salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder.
2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES
-
Page/Page column 39-40, (2008/06/13)
The present invention relates to compounds of formula (I), or to salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof. Formula (I) wherein R1 is a group selected from: Formulas (A), (B), (C)
